Product Categories
| Country: | China |
|---|---|
| Tel: | 025-025-58851786 |
| Mobile: | 17714337195 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 4-((4-Bromobenzyl)oxy)quinazoline | C15H11BrN2O | 737818-56-3 | Details |
| 1H-Benzimidazole-6-carboximidamide, 2,2'-[(2-fluoro-1,3-phenylene)bis(methyleneoxy-4,1-phenylene)]bis[N-(1-methylethyl)-, hydrochloride (1:4) | C42H42ClFN8O2 | 2170606-75-2 | Details |
| LMTK3 inibitor C28 | C18H11F3N4O | 2764850-23-7 | Details |
| COMPOUND 401 | C16H15N3O2 | 168425-64-7 | Details |
| N-(4-Ethoxyphenyl)-4-(2-methylimidazo[1,2-a]pyridin-3-yl)thiazol-2-amine | C19H18N4OS | 315703-52-7 | Details |
| 1H-Thieno[3,4-d]iMidazole-4-pentanaMide, N-[2-(4-aMinophenyl)ethyl]hexahydro-2-oxo-, (3aS,4S,6aR)- | C18H26N4O2S | 769933-15-5 | Details |
| OTS964 | C23H24N2O2S | 1338545-07-5 | Details |
| 2-(4-(Cyclohexylmethyl)piperazin-1-yl)-8-nitro-6-(trifluoromethyl)-4H-benzo[e][1,3]thiazin-4-one | C20H23F3N4O3S | 1377239-83-2 | Details |
| Qstatin | C7H5BrN2O2S2 | 902688-24-8 | Details |
| DJ-V159 | C24H12F6N4O2 | 2253744-53-3 | Details |
| CA-5f | C24H24N2O3 | 1370032-19-1 | Details |
| Tubulin inhibitor 6 | C20H14ClNO2S | 105925-39-1 | Details |
| Martinostat | C22H30N2O2 | 1629052-58-9 | Details |
| Pyroxamide | C13H19N3O3 | 382180-17-8 | Details |
| STM2120 | 2762286-04-2 | Details |
| 942436-93-3 | C20H22N4O3 | 942436-93-3 | Details |
| ML213 | C17H23NO | 489402-47-3 | Details |
| 6,7-dimethoxy-N-(4-nitrophenyl)quinazolin-4-amine | C16H14N4O4 | 765899-28-3 | Details |
| Methyl 8-(tert-butyl)-6-chloroimidazo[1,2-b]pyridazine-2-carboxylate | C12H14ClN3O2 | 1690176-75-0 | Details |
| N-(4-(7-Chloro-2H-benzo[b][1,4]oxazin-3-yl)phenyl)acetamide | C16H13ClN2O2 | 1798331-92-6 | Details |
| Bractoppin | C25H23FN4O | 2290527-07-8 | Details |
| DB2313(DB 2313) | C42H41FN8O2 | 2170606-74-1 | Details |
| IT603) | C11H9BrN2O3S | 292168-90-2 | Details |
| 5-(4-HYDROXY-BENZYLIDENE)-PYRIMIDINE-2,4,6-TRIONE | C11H8N2O4 | 27406-31-1 | Details |
| Carbamic acid, (3-mercaptopropyl)-, 1,1-dimethylethyl ester (9CI) | C8H17NO2S | 93472-93-6 | Details |
| NAT | C18H21NO3 | 831243-31-3 | Details |
| hCAII-IN-8 | C15H16N2O5S | 952306-80-8 | Details |
| 7-Bromo-2-(4-hydroxyphenyl)-1,3-benzoxazol-5-ol | C13H8BrNO3 | 440122-66-7 | Details |
| SR 1078 | C17H10F9NO2 | 1246525-60-9 | Details |
| Boronic acid, B-[4-[[4-[(Z)-[3-[(4-fluorophenyl)Methyl]-2,4-dioxo-5-thiazolidinylidene]Methyl]phenoxy]Methyl]phenyl]- | C24H19BFNO5S | 1312201-00-5 | Details |
| 5-(4-iodobenzylidene)rhodanine | C10H6INOS2 | 90947-00-5 | Details |
| N-(4-nitrophenyl)-2-thiophen-2-ylacetamide | C12H10N2O3S | 384857-54-9 | Details |
| Roquinimex | C18H16N2O3 | 84088-42-6 | Details |
| 3,4-Dimethoxy-N-(5-methylisoxazol-3-yl)benzamide | C13H14N2O4 | 309951-18-6 | Details |
| 4,4'-Oxybis[benzamide | C14H12N2O3 | 6336-34-1 | Details |
| Acetamide, N-[4-(6-chloro-2-quinoxalinyl)phenyl]- | C16H12ClN3O | 2412270-22-3 | Details |
| Peficitinib | C18H22N4O2 | 944118-01-8 | Details |
| N1,N2-Bis[[4-(2-pyridinyl)phenyl]methyl]- 1,2-ethanediamine | C26H26N4 | 1507370-20-8 | Details |
| 224169-27-1 | C24H25NO4 | 224169-27-1 | Details |
| Kdu691 | C22H18ClN5O2 | 1513879-19-0 | Details |
| FArampator | C12H13N3O2 | 211735-76-1 | Details |
| SULFAPHENAZOLE | C15H14N4O2S | 526-08-9 | Details |
| ML239 | C13H10Cl3N3O2 | 1378872-36-6 | Details |
| 5-(3-(4-Methoxyphenyl)allylidene)pyrimidine-2,4,6(1H,3H,5H)-trione | C14H12N2O4 | 100872-83-1 | Details |
| URB602 | C19H21NO2 | 565460-15-3 | Details |
| 3,5-Bis(3,4-dichlorobenzylidene)piperidin-4-one | C19H13Cl4NO | 145888-79-5 | Details |
| IU1-47 | Deubiquitinase | C19H23ClN2O | 670270-31-2 | Details |
| ARANIDIPINE | C19H20N2O7 | 86780-90-7 | Details |
| Auxinole | C20H19NO3 | 86445-22-9 | Details |
| 1821143-80-9 | C19H15NO2 | 1821143-80-9 | Details |
| PRL-3 INHIBITOR I | C17H11Br2NO2S2 | 893449-38-2 | Details |
| (S)-Methyl 2-hexanamido-3-(4-hydroxyphenyl)propanoate | C16H23NO4 | 1104874-94-3 | Details |
| Etosalamide | C11H15NO3 | 15302-15-5 | Details |
| 4-[[3,4-(METHYLENEDIOXY)BENZYL]AMINO]-6-CHLOROQUINAZOLINE | C16H12ClN3O2 | 150450-53-6 | Details |
| GAK inhibitor 49 | C20H22N2O5 | 319492-82-5 | Details |
| Soticlestat | C23H23N3O2 | 1429505-03-2 | Details |
| TH34 | C15H16N2O2 | 2196203-96-8 | Details |
| GW284543 | C23H20N2O3 | 790186-68-4 | Details |
| 4-CHLORO-2-NITRO-1-(PHENYLSULFONYL)BENZENE | C12H8ClNO4S | 86030-08-2 | Details |
| FH 535 | C13H10Cl2N2O4S | 108409-83-2 | Details |
| VU0238441 | C16H9ClF3NO2 | 85511-68-8 | Details |
| Aurora Kinase Inhibitor II | C23H20N4O3 | 331770-21-9 | Details |
| PKC-theta inhibitor | C20H25F3N6O3 | 736048-65-0 | Details |
| ETH 2120 | C34H52N2O4 | 81686-22-8 | Details |
| Tasisulam | C11H6BrCl2NO3S2 | 519055-62-0 | Details |
| 2,3-BIS(BROMOMETHYL)QUINOXALINE 1,4-DIOXIDE | C10H8Br2N2O2 | 18080-67-6 | Details |
| AG348;AG348;AG-348 | C24H26N4O3S | 1260075-17-9 | Details |
| CYM 5541 | C19H28N2O2 | 945128-26-7 | Details |
| HJC0197 | C19H21N3OS | 1383539-73-8 | Details |
| BQR695 | C19H20N4O3 | 1513879-21-4 | Details |
| CS-2729 | C16H12F5N3O | 2137047-43-7 | Details |
| NSC 95397 | C14H14O4S2 | 93718-83-3 | Details |
| SGC-GAK-1 | C18H17BrN2O3 | 2226517-76-4 | Details |
| 5-(1-Methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide | C25H20F3N5O2 | 2095849-04-8 | Details |
| NQ301 | C18H12ClNO3 | 130089-98-4 | Details |
| TCPOBOP | C16H8Cl4N2O2 | 76150-91-9 | Details |
| 1-(4-BROMOBENZYL)INDOLE-2,3-DIONE | C15H10BrNO2 | 79183-37-2 | Details |
| AS 1269574 | C13H14BrN3O | 330981-72-1 | Details |
| L 2-401 | C16H13FN2O2S | 883050-24-6 | Details |
| 1140964-99-3 | C18H15N5O | 1140964-99-3 | Details |
| M-3M3FBS | C16H16F3NO2S | 200933-14-8 | Details |
| 3-fluoro-N'-[(E)-(5-nitrothiophen-2-yl)methylidene]benzohydrazide | C12H8FN3O3S | 394694-98-5 | Details |
| 1H-Indole-6-sulfonamide, 5-bromo-N-[4-chloro-3-(trifluoromethyl)phenyl]-1-(cyclopropylcarbonyl)-2,3-dihydro- | C19H15BrClF3N2O3S | 1207660-00-1 | Details |
| N-(4-methoxyphenyl)-2-quinoxalinecarboxamide | C16H13N3O2 | 901599-43-7 | Details |
| Robenacoxib | C16H13F4NO2 | 220991-32-2 | Details |
| ICA 069673 | C11H6ClF2N3O | 582323-16-8 | Details |
| PIK-75 Hydrochloride | C16H15BrClN5O4S | 372196-77-5 | Details |
| SKLB1002 | C13H12N4O2S2 | 1225451-84-2 | Details |
| 2-Methoxy-N-(3-(3-methylbenzamido)phenyl)benzamide | C22H20N2O3 | 947914-18-3 | Details |
| VUF 10460 | C15H19N5 | 1028327-66-3 | Details |
| NSC59984,NCI59984 | C12H15N3O4 | 803647-40-7 | Details |
| Ethyl 2-(2-chlorobenzyl)acrylate | C12H13ClO2 | 866028-26-4 | Details |
| OTS514 hydrochloride | C21H21ClN2O2S | 2319647-76-0 | Details |
| Mitochonic Acid 5 | C18H13F2NO3 | 1354707-41-7 | Details |
| N-[5-bromo-1-[(4-fluorophenyl)methyl]-4-methyl-2-oxopyridin-3-yl]cycloheptanecarboxamide | C21H24BrFN2O2 | 2244579-87-9 | Details |
| Product Total： Product Page： | ||||
| 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 | ||||